It is the goal of the corporation to help resolve some of the underlying molecular underpinnings found in neuroimmune diseases, particularly autism, with treatment protocols that may improve the quality of life among this patient population. Providers should be informed of the unique health factors and outcomes associated with autism. Clear descriptions of the critical pathways and molecular functioning within this population will be fully detailed. Health care practitioners will gain crucial information on epigenetics and the importance of prevention strategies. An evidence-based approach in providing care will be fundamental in minimizing the negative associated risks and outcomes among this population.
It is the mission of the RNI, as a continuing education provider, to disseminate research information, which will increase access to health care and improve the quality of life of individuals with neurological disorders. The Web-based instruction of health service providers will teach innovative screenings, phenotype assays, therapeutics, and diagnostic developments for neurological disorders. The corporate mission shall be fulfilled by inspiring, educating, and problem-solving with participating providers. The primary function of the RNI is the intent to bridge the information gap between research evidence and family practice with the integration of multidisciplinary teams and recognizing the value of patient-centered care.
Every patient with a mental health diagnosis will have access to care.
Individuals may donate to this 301(c)(3) or you can purchase the leading CBD oil on the market today; UltraCell